mTOR Inhibitors for Treatment of Low-Risk Prostate Cancer

Prostate cancer incidence increases with age; along with many other cancers, it could be considered a disease of aging. Prostate cancer screening has led to a significant proportion of men diagnosed with low-grade, low-stage prostate cancer who are now more likely to choose an active surveillance st...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Med Hypotheses
Asıl Yazarlar: Liss, Michael A., Rickborn, Lanette, DiGiovanni, John, Bacich, Dean, DeGraffenried, Linda A., Parihar, Manish, Thompson, Ian M., Dave Sharp, Zelton
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2018
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6902872/
https://ncbi.nlm.nih.gov/pubmed/30077200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mehy.2018.06.004
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller